Antiphospholipid syndrome and the neurologist: from pathogenesis to therapy

T Fleetwood, R Cantello, C Comi - Frontiers in neurology, 2018 - frontiersin.org
Antiphospholipid syndrome (APS) is an autoimmune antibody-mediated condition
characterized by thrombotic events and/or pregnancy morbidity in association with persistent …

Treatment in thrombotic antiphospholipid syndrome: a review

TS Vadgama, A Smith, ML Bertolaccini - Lupus, 2019 - journals.sagepub.com
Antiphospholipid syndrome an autoimmune disease characterized by thrombosis and/or
pregnancy morbidity alongside the presence of antiphospholipid antibodies (aPL). This …

Damage index for antiphospholipid syndrome during long term follow-up: correlation between organ damage accrual and quality of life

G Medina, EA Cimé Aké, O Vera-Lastra… - Lupus, 2021 - journals.sagepub.com
Background Consequences of organ damage in primary antiphospholipid syndrome (PAPS)
are diverse, our aim was to determine organ damage over time and the correlation of organ …

Immunogenicity, safety, and antiphospholipid antibodies after SARS-CoV-2 vaccine in patients with primary antiphospholipid syndrome

F Signorelli, GGM Balbi, NE Aikawa, CA Silva… - Lupus, 2022 - journals.sagepub.com
Objective Coronavirus disease 19 (COVID-19) has an increased risk of coagulopathy with
high frequency of antiphospholipid antibodies (aPL). Recent reports of thrombosis …

Antiphospholipid Syndrome Committee of the Brazilian Society of Rheumatology position statement on the use of direct oral anticoagulants (DOACs) in …

GGM Balbi, MS Pacheco, OA Monticielo… - Advances in …, 2020 - Springer
Abstract Background The term Direct Oral Anticoagulants (DOACs) refers to a group of drugs
that inhibit factor Xa or thrombin. Even though their use for treating different thrombotic or …

[HTML][HTML] A simplified understanding of the black swan: anti-phospholipid antibody syndrome

B Vaidya, S Nakarmi, R Joshi… - JNMA: Journal of the Nepal …, 2019 - ncbi.nlm.nih.gov
ABSTRACT Anti-phospholipid Antibody Syndrome or Hugh's syndrome is a heterogeneous
disorder, first fully described in 1980s. The syndrome is caused by the presence of specific …

[PDF][PDF] Антифосфоліпідний синдром під маскою легеневої патології: клінічні спостереження пульмонолога

ОК Яковенко, СЛ Гріфф… - Алергологія. Інфектологія, 2019 - researchgate.net
Антифосфоліпідний синдром (АФС)–це системне автоімунне захворювання, яке
характеризується тромботичними або акушерськими подіями, що виникають у пацієнтів …

Frequência e impacto da apneia obstrutiva do sono em pacientes portadores da síndrome antifosfolípide primária trombótica

GGM Balbi - 2024 - teses.usp.br
Introdução: A apneia obstrutiva do sono (AOS) se associa com um aumento no risco de
doenças cardiovasculares e cerebrovasculares. O entendimento do impacto da AOS nos …

[PDF][PDF] 血栓性抗磷脂综合征的治疗进展

吴迪, 李英豪, 赵宁, 刘斌 - 大连医科大学学报, 2020 - jcme.org.cn
抗磷脂综合征(antiphospholipidsyndrome, APS) 是一种全身性的自身免疫性疾病,
以血管血栓形成或妊娠并发症为特征, 伴有持续阳性的抗磷脂抗体(aPL), 包括狼疮抗凝物(LA) …

Effectiveness of Anticoagulant Therapy for Antiphospholipid Syndrome: Protocol for a systematic review of randomised trials with focus on outcome reporting

JBH Adelhelm - lupus.bmj.com
ABSTRACT Background: Antiphospholipid Syndrome (APS) is defined as a systemic
autoimmune disorder characterised by venous or arterial thrombosis and/or pregnancy …